âčïž Skipped - page is already crawled
| Filter | Status | Condition | Details |
|---|---|---|---|
| HTTP status | PASS | download_http_code = 200 | HTTP 200 |
| Age cutoff | PASS | download_stamp > now() - 6 MONTH | 1.6 months ago |
| History drop | PASS | isNull(history_drop_reason) | No drop reason |
| Spam/ban | PASS | fh_dont_index != 1 AND ml_spam_score = 0 | ml_spam_score=0 |
| Canonical | PASS | meta_canonical IS NULL OR = '' OR = src_unparsed | Not set |
| Property | Value |
|---|---|
| URL | https://www.nytimes.com/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html |
| Last Crawled | 2026-03-03 12:53:59 (1 month ago) |
| First Indexed | 2020-12-16 17:28:17 (5 years ago) |
| HTTP Status Code | 200 |
| Meta Title | Health Care Worker Had Serious Allergic Reaction After Pfizer's Covid Vaccine - The New York Times |
| Meta Description | One of the workers, who did not have a history of allergies, remained in the hospital on Wednesday night. Some reactions to the vaccine were also reported last week in Britain. |
| Meta Canonical | null |
| Boilerpipe Text | Advertisement
SKIP ADVERTISEMENT
One of the workers, who did not have a history of allergies, remained in the hospital on Wednesday night. Some reactions to the vaccine were also reported last week in Britain.
Vaccines being prepared in Fargo, N.D., on Monday. The reaction was believed to be similar to the reactions two health workers in Britain experienced after receiving the Pfizer vaccine last week. They both recovered.
Credit...
Tim Gruber for The New York Times
Published Dec. 16, 2020
Updated Dec. 22, 2020
Two health care workers at the same hospital in Alaska developed concerning reactions just minutes after receiving
Pfizerâs coronavirus vaccine
this week, including one staff member who was to remain hospitalized until Thursday.
Health officials said that the cases would not disrupt their
vaccine rollout
plans and that they were sharing the information for the sake of transparency.
The first worker, a middle-aged woman who had no history of allergies, had an anaphylactic reaction that began 10 minutes after receiving the vaccine at Bartlett Regional Hospital in Juneau on Tuesday, a hospital official said. She experienced a rash over her face and torso, shortness of breath and an elevated heart rate.
Dr. Lindy Jones, the hospitalâs emergency department medical director, said the worker was first given a shot of epinephrine, a standard treatment for severe
allergic reactions
. Her symptoms subsided but then re-emerged, and she was treated with steroids and an epinephrine drip.
When doctors tried to stop the drip, her symptoms re-emerged yet again, so the woman was moved to the intensive care unit, observed throughout the night, then weaned off the drip early Wednesday morning, Dr. Jones said.
Dr. Jones had said earlier Wednesday that the woman was set to be discharged in the evening, but the hospital said late Wednesday that she was remaining another night.
The second worker received his shot on Wednesday and developed eye puffiness, lightheadedness and a scratchy throat 10 minutes after the injection, the hospital said in a statement. He was taken to the emergency room and treated with epinephrine, Pepcid and Benadryl, although the hospital said the reaction was not considered anaphylaxis. The worker was back to normal within an hour and released.
The hospital, which had administered 144 total doses as of Wednesday night, said both workers did not want their experiences to have a negative impact on others lining up for the vaccine.
âWe have no plans to change our vaccine schedule, dosing or regimen,â Dr. Anne Zink, Alaskaâs chief medical officer, said in a statement.
Although the Pfizer vaccine was shown to be safe and about 95 percent effective in a clinical trial involving 44,000 participants, the Alaska cases will likely intensify concerns about possible side effects. Experts said the developments may prompt calls for tighter guidelines to ensure that recipients were carefully monitored for adverse reactions.
Dr. Paul A. Offit, a vaccine expert and member of an outside advisory panel that recommended the Food and Drug Administration authorize the Pfizer vaccine for emergency use, said the appropriate precautions were already in place. For instance, he said, the requirement that recipients remain in place for 15 minutes after getting the vaccine helped ensure the woman was quickly treated.
âI donât think this means we should pauseâ vaccine distribution, he said. âNot at all.â But he said researchers need to figure out âwhat component of the vaccine is causing this reaction.â
Dr. Jay Butler, a top infectious-disease expert with the Centers for Disease Control and Prevention, said the Alaska situation showed that the monitoring system worked. The agency has recommended that the vaccine be administered in settings that have supplies, including oxygen and epinephrine, to manage anaphylactic reactions.
Millions of Americans are in line to be inoculated with the Pfizer vaccine by the end of the year. As of Wednesday night, it was unclear how many Americans so far have received it. Alex M. Azar II, the health and human services secretary, said his department would be releasing that data âseveral days or maybe a week into this.â
The Alaska womanâs reaction was believed to be similar to the anaphylactic reactions two health workers in Britain experienced after receiving the Pfizer-BioNTech vaccine last week. Like her, both recovered.
Those cases are expected to come up on Thursday, when F.D.A. scientists are scheduled to meet with the agencyâs outside panel of experts to decide whether to recommend that regulators approve Modernaâs Covid-19 vaccine for emergency use.
Although the Moderna and Pfizer-BioNTech vaccines are based on the same type of technology and similar in their ingredients, it is not clear whether an allergic reaction to one would occur with the other. Both consist of genetic material called mRNA encased in a bubble of oily molecules called lipids, although they use different combinations of lipids.
Dr. Offit said that in both vaccines, the bubbles are coated with a stabilizing molecule called polyethylene glycol that he considered a âleading contenderâ for triggering an allergic reaction. He stressed that more investigation was needed.
Pfizerâs trial
did not find any serious adverse events
caused by the vaccine, although many participants did experience aches, fevers and other side effects. The Alaska reactions were assumed to be related to the vaccine because they occurred so quickly after the shot.
A Pfizer spokeswoman, Jerica Pitts, said the company did not yet have all of the details of the Alaska situation but was working with local health authorities. The vaccine comes with information warning that medical treatment should be available in case of a rare anaphylactic event, she said. âWe will closely monitor all reports suggestive of serious allergic reactions following vaccination and update labeling language if needed,â Ms. Pitts said.
After the workers in Britain fell ill, authorities there warned against giving the vaccines to anyone with a history of severe allergic reactions. They later
clarified their concerns,
changing the wording from âsevere allergic reactionsâ to specify that the vaccine should not be given to anyone who has ever had an anaphylactic reaction to a food, medicine or vaccine. That type of reaction to a vaccine is âvery rare,â they said.
Pfizer officials have said the two British people who had the reaction had a history of severe allergies. One, a 49-year-old woman, had a history of egg allergies. The other, a 40-year-old woman, had a history of allergies to several medications. Both carried EpiPen-like devices to inject themselves with epinephrine in case of such a reaction.
Pfizer has said that its vaccine does not contain egg ingredients.
The British update also said that a third patient had a âpossible allergic reaction,â but did not describe it.
In the United States, federal regulators issued a broad authorization for the vaccine on Friday to adults 16 years and older. Health care providers were warned not to give the vaccine to anyone with a âknown history of a severe allergic reactionâ to any component of the vaccine, which they said was a standard warning for vaccines.
But because of the British cases, F.D.A. officials have said they would require Pfizer to increase its monitoring for anaphylaxis and submit data on it once the vaccine comes into further use. Pfizer also said the vaccine was recommended to be administered in settings that have access to equipment to manage anaphylaxis. Last weekend, the C.D.C. said people with serious allergies could be safely vaccinated, with close monitoring for 30 minutes after receiving the shot.
Anaphylaxis can be life-threatening, with impaired breathing and drops in blood pressure that usually occur within minutes or even seconds after exposure to a food or medicine, or even a substance like latex to which the person is allergic.
Carl Zimmer contributed reporting.
Noah Weiland
is a reporter in the Washington bureau of The New York Times, covering health care. He was raised in East Lansing, Michigan and graduated from the University of Chicago.
Sharon LaFraniere
is an investigative reporter. She was part of a team that won a Pulitzer Prize in 2018 for national reporting on Donald Trumpâs connections with Russia.
Mike Baker
is the Seattle bureau chief, reporting primarily from the Northwest and Alaska.
Katie Thomas
covers the business of health care, with a focus on the drug industry. She started at The Times in 2008 as a sports reporter.
A version of this article appears in print on
Dec. 17, 2020
, Section A, Page 7 of the New York edition with the headline: Health Worker Hospitalized After Vaccine
.
Order Reprints
|
Todayâs Paper
|
Subscribe
Related Content
The Covid-19 Pandemic
Eric Lee/The New York Times
Tierney L. Cross/The New York Times
Andrea Verdelli for The New York Times
More in Health
Kholood Eid for The New York Times
Lucy Lu for The New York Times
Warrick Page/HBO Max
Federica Bordoni
Editorsâ Picks
Christopher Testani for The New York Times. Food Stylist: Simon Andrews.
Alexandre Juillet/Chamonix-Mont Blanc
Trending in The Times
Illustration by Richard a Chance
Photo Illustration by Ioulex for The New York Times
Janet Mac
Lauren Petracca for The New York Times
Noah Kalina for The New York Times
Jason Schmidt
Kent Edwards/Reuters
Aleksey Kondratyev for The New York Times
National Portrait Gallery, London
Scott McIntyre for The New York Times
Advertisement
SKIP ADVERTISEMENT |
| Markdown | [Skip to content](https://www.nytimes.com/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html#site-content)[Skip to site index](https://www.nytimes.com/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html#site-index)
Search & Section Navigation
Section Navigation
Search
[Health](https://www.nytimes.com/section/health)
[Log in](https://myaccount.nytimes.com/auth/login?response_type=cookie&client_id=vi&redirect_uri=https%3A%2F%2Fwww.nytimes.com%2Fsubscription%2Fonboarding-offer%3FcampaignId%3D7JFJX%26EXIT_URI%3Dhttps%253A%252F%252Fwww.nytimes.com%252F2020%252F12%252F16%252Fhealth%252Fcovid-pfizer-vaccine-allergic-reaction.html&asset=masthead)
Tuesday, March 3, 2026
[Todayâs Paper](https://www.nytimes.com/section/todayspaper)
U.S. Health Policy
- [Vaccine Schedule Lawsuit](https://www.nytimes.com/2026/02/24/health/vaccine-schedule-california-lawsuit.html)
- [Moderna Flu Vaccine](https://www.nytimes.com/2026/02/18/health/fda-moderna-flu-vaccine-mrna.html)
- [Covid Shots](https://www.nytimes.com/2026/02/06/health/vaccines-covid-acip-malone-kennedy.html)
- [âNaturally Derivedâ Dyes](https://www.nytimes.com/2026/02/05/us/politics/kennedy-fda-food-dyes-protein.html)
- [Approach to Immunization](https://www.nytimes.com/2026/01/11/health/kennedy-vaccines-children.html)
Advertisement
[SKIP ADVERTISEMENT](https://www.nytimes.com/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html#after-top)
Supported by
[SKIP ADVERTISEMENT](https://www.nytimes.com/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html#after-sponsor)
# 2 Alaska Health Workers Got Emergency Treatment After Receiving Pfizerâs Vaccine
One of the workers, who did not have a history of allergies, remained in the hospital on Wednesday night. Some reactions to the vaccine were also reported last week in Britain.
- Share full article

Vaccines being prepared in Fargo, N.D., on Monday. The reaction was believed to be similar to the reactions two health workers in Britain experienced after receiving the Pfizer vaccine last week. They both recovered.Credit...Tim Gruber for The New York Times
By [Noah Weiland](https://www.nytimes.com/by/noah-weiland)[Sharon LaFraniere](https://www.nytimes.com/by/sharon-lafraniere)[Mike Baker](https://www.nytimes.com/by/mike-baker) and [Katie Thomas](https://www.nytimes.com/by/katie-thomas)
Published Dec. 16, 2020Updated Dec. 22, 2020
Two health care workers at the same hospital in Alaska developed concerning reactions just minutes after receiving [Pfizerâs coronavirus vaccine](https://www.nytimes.com/2020/12/22/us/pfizer-vaccine-doses.html) this week, including one staff member who was to remain hospitalized until Thursday.
Health officials said that the cases would not disrupt their [vaccine rollout](https://www.nytimes.com/2020/12/21/world/europe/eu-coronavirus-vaccine.html) plans and that they were sharing the information for the sake of transparency.
The first worker, a middle-aged woman who had no history of allergies, had an anaphylactic reaction that began 10 minutes after receiving the vaccine at Bartlett Regional Hospital in Juneau on Tuesday, a hospital official said. She experienced a rash over her face and torso, shortness of breath and an elevated heart rate.
Dr. Lindy Jones, the hospitalâs emergency department medical director, said the worker was first given a shot of epinephrine, a standard treatment for severe [allergic reactions](https://www.nytimes.com/2020/12/18/health/covid-vaccine-allergies.html). Her symptoms subsided but then re-emerged, and she was treated with steroids and an epinephrine drip.
When doctors tried to stop the drip, her symptoms re-emerged yet again, so the woman was moved to the intensive care unit, observed throughout the night, then weaned off the drip early Wednesday morning, Dr. Jones said.
Dr. Jones had said earlier Wednesday that the woman was set to be discharged in the evening, but the hospital said late Wednesday that she was remaining another night.
The second worker received his shot on Wednesday and developed eye puffiness, lightheadedness and a scratchy throat 10 minutes after the injection, the hospital said in a statement. He was taken to the emergency room and treated with epinephrine, Pepcid and Benadryl, although the hospital said the reaction was not considered anaphylaxis. The worker was back to normal within an hour and released.
The hospital, which had administered 144 total doses as of Wednesday night, said both workers did not want their experiences to have a negative impact on others lining up for the vaccine.
âWe have no plans to change our vaccine schedule, dosing or regimen,â Dr. Anne Zink, Alaskaâs chief medical officer, said in a statement.
## Editorsâ Picks
[Resorts That Are Family Friendly and Actually Cool](https://www.nytimes.com/2026/02/28/t-magazine/resorts-that-are-family-friendly-and-actually-cool.html)
[My Aging Mother Wonât Stop Driving. Should I Take Away Her Keys?](https://www.nytimes.com/2026/02/28/magazine/aging-mother-driving-ethics.html)
[Among the Elites, Who Decides What Exploitation Looks Like?](https://www.nytimes.com/2026/03/02/style/industry-season-finale-chat-elites.html)
Advertisement
[SKIP ADVERTISEMENT](https://www.nytimes.com/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html#after-pp_edpick)
Although the Pfizer vaccine was shown to be safe and about 95 percent effective in a clinical trial involving 44,000 participants, the Alaska cases will likely intensify concerns about possible side effects. Experts said the developments may prompt calls for tighter guidelines to ensure that recipients were carefully monitored for adverse reactions.
Dr. Paul A. Offit, a vaccine expert and member of an outside advisory panel that recommended the Food and Drug Administration authorize the Pfizer vaccine for emergency use, said the appropriate precautions were already in place. For instance, he said, the requirement that recipients remain in place for 15 minutes after getting the vaccine helped ensure the woman was quickly treated.
âI donât think this means we should pauseâ vaccine distribution, he said. âNot at all.â But he said researchers need to figure out âwhat component of the vaccine is causing this reaction.â
Dr. Jay Butler, a top infectious-disease expert with the Centers for Disease Control and Prevention, said the Alaska situation showed that the monitoring system worked. The agency has recommended that the vaccine be administered in settings that have supplies, including oxygen and epinephrine, to manage anaphylactic reactions.
Millions of Americans are in line to be inoculated with the Pfizer vaccine by the end of the year. As of Wednesday night, it was unclear how many Americans so far have received it. Alex M. Azar II, the health and human services secretary, said his department would be releasing that data âseveral days or maybe a week into this.â
[How the Pfizer-BioNTech Vaccine Works Two shots can prime the immune system to fight the coronavirus.](https://www.nytimes.com/interactive/2020/health/pfizer-biontech-covid-19-vaccine.html)
The Alaska womanâs reaction was believed to be similar to the anaphylactic reactions two health workers in Britain experienced after receiving the Pfizer-BioNTech vaccine last week. Like her, both recovered.
Those cases are expected to come up on Thursday, when F.D.A. scientists are scheduled to meet with the agencyâs outside panel of experts to decide whether to recommend that regulators approve Modernaâs Covid-19 vaccine for emergency use.
Although the Moderna and Pfizer-BioNTech vaccines are based on the same type of technology and similar in their ingredients, it is not clear whether an allergic reaction to one would occur with the other. Both consist of genetic material called mRNA encased in a bubble of oily molecules called lipids, although they use different combinations of lipids.
Dr. Offit said that in both vaccines, the bubbles are coated with a stabilizing molecule called polyethylene glycol that he considered a âleading contenderâ for triggering an allergic reaction. He stressed that more investigation was needed.
Pfizerâs trial [did not find any serious adverse events](https://www.nytimes.com/2020/12/08/health/covid-vaccine-pfizer.html) caused by the vaccine, although many participants did experience aches, fevers and other side effects. The Alaska reactions were assumed to be related to the vaccine because they occurred so quickly after the shot.
A Pfizer spokeswoman, Jerica Pitts, said the company did not yet have all of the details of the Alaska situation but was working with local health authorities. The vaccine comes with information warning that medical treatment should be available in case of a rare anaphylactic event, she said. âWe will closely monitor all reports suggestive of serious allergic reactions following vaccination and update labeling language if needed,â Ms. Pitts said.
After the workers in Britain fell ill, authorities there warned against giving the vaccines to anyone with a history of severe allergic reactions. They later [clarified their concerns,](https://www.gov.uk/government/news/confirmation-of-guidance-to-vaccination-centres-on-managing-allergic-reactions-following-covid-19-vaccination-with-the-pfizer-biontech-vaccine) changing the wording from âsevere allergic reactionsâ to specify that the vaccine should not be given to anyone who has ever had an anaphylactic reaction to a food, medicine or vaccine. That type of reaction to a vaccine is âvery rare,â they said.
Pfizer officials have said the two British people who had the reaction had a history of severe allergies. One, a 49-year-old woman, had a history of egg allergies. The other, a 40-year-old woman, had a history of allergies to several medications. Both carried EpiPen-like devices to inject themselves with epinephrine in case of such a reaction.
Pfizer has said that its vaccine does not contain egg ingredients.
The British update also said that a third patient had a âpossible allergic reaction,â but did not describe it.
In the United States, federal regulators issued a broad authorization for the vaccine on Friday to adults 16 years and older. Health care providers were warned not to give the vaccine to anyone with a âknown history of a severe allergic reactionâ to any component of the vaccine, which they said was a standard warning for vaccines.
But because of the British cases, F.D.A. officials have said they would require Pfizer to increase its monitoring for anaphylaxis and submit data on it once the vaccine comes into further use. Pfizer also said the vaccine was recommended to be administered in settings that have access to equipment to manage anaphylaxis. Last weekend, the C.D.C. said people with serious allergies could be safely vaccinated, with close monitoring for 30 minutes after receiving the shot.
Anaphylaxis can be life-threatening, with impaired breathing and drops in blood pressure that usually occur within minutes or even seconds after exposure to a food or medicine, or even a substance like latex to which the person is allergic.
Carl Zimmer contributed reporting.
The Pfizer-BioNTech Vaccine
[![]()The U.K. says people with severe allergies should not take the Pfizer-BioNTech vaccine while two reactions are under investigation. Dec. 9, 2020](https://www.nytimes.com/2020/12/09/world/the-uk-says-people-with-severe-allergies-should-not-take-the-pfizer-biontech-vaccine-while-two-reactions-are-under-investigation.html)
[![]()F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away Dec. 11, 2020](https://www.nytimes.com/2020/12/11/health/pfizer-vaccine-authorized.html)
[![]()Pfizerâs Covid Vaccine and Allergies: How Concerned Should You Be? Dec. 11, 2020](https://www.nytimes.com/2020/12/11/health/Covid-Pfizer-vaccine-allergies.html)
[Noah Weiland](https://www.nytimes.com/by/noah-weiland) is a reporter in the Washington bureau of The New York Times, covering health care. He was raised in East Lansing, Michigan and graduated from the University of Chicago.
[Sharon LaFraniere](https://www.nytimes.com/by/sharon-lafraniere) is an investigative reporter. She was part of a team that won a Pulitzer Prize in 2018 for national reporting on Donald Trumpâs connections with Russia.
[Mike Baker](https://www.nytimes.com/by/mike-baker) is the Seattle bureau chief, reporting primarily from the Northwest and Alaska.
[Katie Thomas](https://www.nytimes.com/by/katie-thomas) covers the business of health care, with a focus on the drug industry. She started at The Times in 2008 as a sports reporter.
A version of this article appears in print on Dec. 17, 2020, Section A, Page 7 of the New York edition with the headline: Health Worker Hospitalized After Vaccine. [Order Reprints](https://nytimes.wrightsmedia.com/) \| [Todayâs Paper](https://www.nytimes.com/section/todayspaper) \| [Subscribe](https://www.nytimes.com/subscriptions/Multiproduct/lp8HYKU.html?campaignId=48JQY)
See more on: [Pfizer Inc.](https://www.nytimes.com/topic/company/pfizer-inc)
- Share full article
## Related Content
### [The Covid-19 Pandemic](https://www.nytimes.com/news-event/coronavirus)
- [C.D.C.âs New Acting Director Draws Unexpected Praise From Agency Staff](https://www.nytimes.com/2026/02/26/health/cdc-bhattacharya-vaccinations-measles.html)

Eric Lee/The New York Times
- [Trump Administration Tells States It Aims to âReimagineâ Jobless Benefits](https://www.nytimes.com/2026/02/24/us/politics/trump-unemployment-benefits-fraud.html)

Tierney L. Cross/The New York Times
- [Chinaâs âKing of Banned Filmsâ Wants to Change the Subject](https://www.nytimes.com/2026/02/20/world/asia/lou-ye-china-film-director.html)
Andrea Verdelli for The New York Times
### [More in Health](https://www.nytimes.com/section/health)
- [Elite Doctors Served Jeffrey Epstein While Treating His âGirlsâ](https://www.nytimes.com/2026/02/28/us/jeffrey-epstein-doctors.html)

Kholood Eid for The New York Times
- [Leah Stavenhagen, Advocate for Young Women With A.L.S., Dies at 33](https://www.nytimes.com/2026/02/23/health/leah-stavenhagen-als.html)

Lucy Lu for The New York Times
- [âThe Pittâ Is Showing Us the Complicated Reality of Psychosis](https://www.nytimes.com/2026/02/26/well/mind/the-pitt-psychosis.html)

Warrick Page/HBO Max
- [Banks Are Becoming Bulwarks for Vulnerable Seniors](https://www.nytimes.com/2026/02/28/health/scams-elderly-banks.html)

Federica Bordoni
### Editorsâ Picks
- [For Actually Good Chicken Breast, Try One of Our Top-Rated Recipes](https://cooking.nytimes.com/article/reader-favorite-boneless-chicken-breast-recipes)

Christopher Testani for The New York Times. Food Stylist: Simon Andrews.
- [A Crisis in the Alps: Airbnb, Climate Change and Americans](https://www.nytimes.com/2026/03/02/travel/french-alps-problems-overdevelopment-climate-change.html)

Alexandre Juillet/Chamonix-Mont Blanc
### Trending in The Times
- [How Selling Out Made Me a Better Artist](https://www.nytimes.com/2026/03/03/magazine/selling-out-art-creativity.html)

Illustration by Richard a Chance
- [Opinion: Trumpâs Head-on-a-Pike Foreign Policy](https://www.nytimes.com/2026/03/03/opinion/ezra-klein-podcast-ben-rhodes.html)

Photo Illustration by Ioulex for The New York Times
- [Opinion: The Reason Gen Z Isnât Dating](https://www.nytimes.com/2026/03/03/opinion/gen-z-dating-clavicular.html)

Janet Mac
- [Rochester, N.Y.: A New Lens on the City of Kodak](https://www.nytimes.com/2026/03/03/realestate/rochester-ny-real-estate-guide.html)

Lauren Petracca for The New York Times
- [That Red Roof! Those Tiffany Lamps! Itâs a Pizza Hut From the Past.](https://www.nytimes.com/2026/03/03/fashion/pizza-hut.html)

Noah Kalina for The New York Times
- [The Artist Transforming His Studio Into a Cathedral of Color](https://www.nytimes.com/2026/03/03/t-magazine/david-novros-soho-studio.html)

Jason Schmidt
- [Takeaways from the Fourth Week of the Alexander Brothers Trial](https://www.nytimes.com/2026/03/02/nyregion/alexanders-trial-takeaways-sex-crime.html)

Kent Edwards/Reuters
- [Opinion: Nine Law Firms Surrendered. Four Law Firms Won.](https://www.nytimes.com/2026/03/03/opinion/law-firms-resistance-trump.html)

Aleksey Kondratyev for The New York Times
- [Book Review: Her Daughters Got the Press. Until Now.](https://www.nytimes.com/2026/03/03/books/review/muv-rachel-trethewey.html)

National Portrait Gallery, London
- [The New Miami Gold Rush](https://www.nytimes.com/2026/03/03/realestate/billionaire-miami-real-estate-zuckerburg.html)

Scott McIntyre for The New York Times
Advertisement
[SKIP ADVERTISEMENT](https://www.nytimes.com/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html#after-bottom)
## Site Index
[Go to Home Page »](https://www.nytimes.com/)
News
- [Home Page](https://www.nytimes.com/)
- [U.S.](https://www.nytimes.com/section/us)
- [World](https://www.nytimes.com/section/world)
- [Politics](https://www.nytimes.com/section/politics)
- [New York](https://www.nytimes.com/section/nyregion)
- [Education](https://www.nytimes.com/section/education)
- [Sports](https://www.nytimes.com/section/sports)
- [Business](https://www.nytimes.com/section/business)
- [Tech](https://www.nytimes.com/section/technology)
- [Science](https://www.nytimes.com/section/science)
- [Weather](https://www.nytimes.com/section/weather)
- [The Great Read](https://www.nytimes.com/spotlight/the-great-read)
- [Obituaries](https://www.nytimes.com/section/obituaries)
- [Headway](https://www.nytimes.com/section/headway)
- [Visual Investigations](https://www.nytimes.com/spotlight/visual-investigations)
- [The Magazine](https://www.nytimes.com/section/magazine)
Arts
- [Book Review](https://www.nytimes.com/section/books/review)
- [Best Sellers Book List](https://www.nytimes.com/books/best-sellers/)
- [Dance](https://www.nytimes.com/section/arts/dance)
- [Movies](https://www.nytimes.com/section/movies)
- [Music](https://www.nytimes.com/section/arts/music)
- [Pop Culture](https://www.nytimes.com/spotlight/pop-culture)
- [Television](https://www.nytimes.com/section/arts/television)
- [Theater](https://www.nytimes.com/section/theater)
- [Visual Arts](https://www.nytimes.com/section/arts/design)
Lifestyle
- [Health](https://www.nytimes.com/section/health)
- [Well](https://www.nytimes.com/section/well)
- [Food](https://www.nytimes.com/section/food)
- [Restaurant Reviews](https://www.nytimes.com/reviews/dining)
- [Love](https://www.nytimes.com/section/fashion/weddings)
- [Travel](https://www.nytimes.com/section/travel)
- [Style](https://www.nytimes.com/section/style)
- [Fashion](https://www.nytimes.com/section/fashion)
- [Real Estate](https://www.nytimes.com/section/realestate)
- [T Magazine](https://www.nytimes.com/section/t-magazine)
Opinion
- [Today's Opinion](https://www.nytimes.com/section/opinion)
- [Columnists](https://www.nytimes.com/section/opinion/columnists)
- [Editorials](https://www.nytimes.com/section/opinion/editorials)
- [Guest Essays](https://www.nytimes.com/section/opinion/contributors)
- [Op-Docs](https://www.nytimes.com/column/op-docs)
- [Letters](https://www.nytimes.com/section/opinion/letters)
- [Sunday Opinion](https://www.nytimes.com/section/opinion/sunday)
- [Opinion Video](https://www.nytimes.com/spotlight/opinion-video)
- [Opinion Audio](https://www.nytimes.com/series/opinion-audio)
More
- [Audio](https://www.nytimes.com/spotlight/podcasts)
- [Games](https://www.nytimes.com/crosswords)
- [Cooking](https://cooking.nytimes.com/)
- [Wirecutter](https://www.nytimes.com/wirecutter/)
- [The Athletic](https://www.nytimes.com/athletic/)
- [Jobs](https://www.nytimes.com/section/jobs)
- [Video](https://www.nytimes.com/video)
- [Graphics](https://www.nytimes.com/spotlight/graphics)
- [Trending](https://www.nytimes.com/trending/)
- [Live Events](https://www.nytimes.com/spotlight/nyt-events)
- [Corrections](https://www.nytimes.com/section/corrections)
- [Reader Center](https://www.nytimes.com/section/reader-center)
- [TimesMachine](https://timesmachine.nytimes.com/browser)
- [The Learning Network](https://www.nytimes.com/section/learning)
- [School of The NYT](https://nytedu.com/)
- [inEducation](https://www.nytimes.com/spotlight/nytimesineducation)
### News
- [Home Page](https://www.nytimes.com/)
- [U.S.](https://www.nytimes.com/section/us)
- [World](https://www.nytimes.com/section/world)
- [Politics](https://www.nytimes.com/section/politics)
- [New York](https://www.nytimes.com/section/nyregion)
- [Education](https://www.nytimes.com/section/education)
- [Sports](https://www.nytimes.com/section/sports)
- [Business](https://www.nytimes.com/section/business)
- [Tech](https://www.nytimes.com/section/technology)
- [Science](https://www.nytimes.com/section/science)
- [Weather](https://www.nytimes.com/section/weather)
- [The Great Read](https://www.nytimes.com/spotlight/the-great-read)
- [Obituaries](https://www.nytimes.com/section/obituaries)
- [Headway](https://www.nytimes.com/section/headway)
- [Visual Investigations](https://www.nytimes.com/spotlight/visual-investigations)
- [The Magazine](https://www.nytimes.com/section/magazine)
### Arts
- [Book Review](https://www.nytimes.com/section/books/review)
- [Best Sellers Book List](https://www.nytimes.com/books/best-sellers/)
- [Dance](https://www.nytimes.com/section/arts/dance)
- [Movies](https://www.nytimes.com/section/movies)
- [Music](https://www.nytimes.com/section/arts/music)
- [Pop Culture](https://www.nytimes.com/spotlight/pop-culture)
- [Television](https://www.nytimes.com/section/arts/television)
- [Theater](https://www.nytimes.com/section/theater)
- [Visual Arts](https://www.nytimes.com/section/arts/design)
### Lifestyle
- [Health](https://www.nytimes.com/section/health)
- [Well](https://www.nytimes.com/section/well)
- [Food](https://www.nytimes.com/section/food)
- [Restaurant Reviews](https://www.nytimes.com/reviews/dining)
- [Love](https://www.nytimes.com/section/fashion/weddings)
- [Travel](https://www.nytimes.com/section/travel)
- [Style](https://www.nytimes.com/section/style)
- [Fashion](https://www.nytimes.com/section/fashion)
- [Real Estate](https://www.nytimes.com/section/realestate)
- [T Magazine](https://www.nytimes.com/section/t-magazine)
### Opinion
- [Today's Opinion](https://www.nytimes.com/section/opinion)
- [Columnists](https://www.nytimes.com/section/opinion/columnists)
- [Editorials](https://www.nytimes.com/section/opinion/editorials)
- [Guest Essays](https://www.nytimes.com/section/opinion/contributors)
- [Op-Docs](https://www.nytimes.com/column/op-docs)
- [Letters](https://www.nytimes.com/section/opinion/letters)
- [Sunday Opinion](https://www.nytimes.com/section/opinion/sunday)
- [Opinion Video](https://www.nytimes.com/spotlight/opinion-video)
- [Opinion Audio](https://www.nytimes.com/series/opinion-audio)
### More
- [Audio](https://www.nytimes.com/spotlight/podcasts)
- [Games](https://www.nytimes.com/crosswords)
- [Cooking](https://cooking.nytimes.com/)
- [Wirecutter](https://www.nytimes.com/wirecutter/)
- [The Athletic](https://www.nytimes.com/athletic/)
- [Jobs](https://www.nytimes.com/section/jobs)
- [Video](https://www.nytimes.com/video)
- [Graphics](https://www.nytimes.com/spotlight/graphics)
- [Trending](https://www.nytimes.com/trending/)
- [Live Events](https://www.nytimes.com/spotlight/nyt-events)
- [Corrections](https://www.nytimes.com/section/corrections)
- [Reader Center](https://www.nytimes.com/section/reader-center)
- [TimesMachine](https://timesmachine.nytimes.com/browser)
- [The Learning Network](https://www.nytimes.com/section/learning)
- [School of The NYT](https://nytedu.com/)
- [inEducation](https://www.nytimes.com/spotlight/nytimesineducation)
### Account
- [Subscribe](https://www.nytimes.com/subscription)
- [Manage My Account](https://www.nytimes.com/account)
- [Home Delivery](https://www.nytimes.com/subscription/home-delivery)
- [Gift Subscriptions](https://www.nytimes.com/gift)
- [Group Subscriptions](https://www.nytimes.com/subscription/groups?Pardot_Campaign_Code_Form_Input=89FQX)
- [Gift Articles](https://www.nytimes.com/gift-articles)
- [Email Newsletters](https://www.nytimes.com/newsletters)
- [NYT Licensing](https://nytlicensing.com/)
- [Replica Edition](https://nytimes.pressreader.com/)
- [Times Store](https://store.nytimes.com/)
## Site Information Navigation
- [© 2026 The New York Times Company](https://help.nytimes.com/hc/en-us/articles/115014792127-Copyright-Notice)
- [NYTCo](https://www.nytco.com/)
- [Contact Us](https://help.nytimes.com/hc/en-us/articles/115015385887-Contact-The-New-York-Times)
- [Accessibility](https://help.nytimes.com/hc/en-us/articles/115015727108-Accessibility)
- [Work with us](https://www.nytco.com/careers/)
- [Advertise](https://advertising.nytimes.com/)
- [T Brand Studio](https://advertising.nytimes.com/custom-content/)
- [Privacy Policy](https://help.nytimes.com/hc/en-us/articles/10940941449492-The-New-York-Times-Company-Privacy-Policy)
- [Cookie Policy](https://www.nytimes.com/privacy/cookie-policy)
- [Terms of Service](https://help.nytimes.com/hc/en-us/articles/115014893428-Terms-of-Service)
- [Terms of Sale](https://help.nytimes.com/hc/en-us/articles/115014893968-Terms-of-Sale)
- [Site Map](https://www.nytimes.com/sitemap/)
- [Canada](https://www.nytimes.com/ca/)
- [International](https://www.nytimes.com/international/)
- [Help](https://help.nytimes.com/hc/en-us)
- [Subscriptions](https://www.nytimes.com/subscription?campaignId=37WXW) |
| Readable Markdown | Advertisement
[SKIP ADVERTISEMENT](https://www.nytimes.com/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html#after-top)
One of the workers, who did not have a history of allergies, remained in the hospital on Wednesday night. Some reactions to the vaccine were also reported last week in Britain.

Vaccines being prepared in Fargo, N.D., on Monday. The reaction was believed to be similar to the reactions two health workers in Britain experienced after receiving the Pfizer vaccine last week. They both recovered.Credit...Tim Gruber for The New York Times
Published Dec. 16, 2020Updated Dec. 22, 2020
Two health care workers at the same hospital in Alaska developed concerning reactions just minutes after receiving [Pfizerâs coronavirus vaccine](https://www.nytimes.com/2020/12/22/us/pfizer-vaccine-doses.html) this week, including one staff member who was to remain hospitalized until Thursday.
Health officials said that the cases would not disrupt their [vaccine rollout](https://www.nytimes.com/2020/12/21/world/europe/eu-coronavirus-vaccine.html) plans and that they were sharing the information for the sake of transparency.
The first worker, a middle-aged woman who had no history of allergies, had an anaphylactic reaction that began 10 minutes after receiving the vaccine at Bartlett Regional Hospital in Juneau on Tuesday, a hospital official said. She experienced a rash over her face and torso, shortness of breath and an elevated heart rate.
Dr. Lindy Jones, the hospitalâs emergency department medical director, said the worker was first given a shot of epinephrine, a standard treatment for severe [allergic reactions](https://www.nytimes.com/2020/12/18/health/covid-vaccine-allergies.html). Her symptoms subsided but then re-emerged, and she was treated with steroids and an epinephrine drip.
When doctors tried to stop the drip, her symptoms re-emerged yet again, so the woman was moved to the intensive care unit, observed throughout the night, then weaned off the drip early Wednesday morning, Dr. Jones said.
Dr. Jones had said earlier Wednesday that the woman was set to be discharged in the evening, but the hospital said late Wednesday that she was remaining another night.
The second worker received his shot on Wednesday and developed eye puffiness, lightheadedness and a scratchy throat 10 minutes after the injection, the hospital said in a statement. He was taken to the emergency room and treated with epinephrine, Pepcid and Benadryl, although the hospital said the reaction was not considered anaphylaxis. The worker was back to normal within an hour and released.
The hospital, which had administered 144 total doses as of Wednesday night, said both workers did not want their experiences to have a negative impact on others lining up for the vaccine.
âWe have no plans to change our vaccine schedule, dosing or regimen,â Dr. Anne Zink, Alaskaâs chief medical officer, said in a statement.
Although the Pfizer vaccine was shown to be safe and about 95 percent effective in a clinical trial involving 44,000 participants, the Alaska cases will likely intensify concerns about possible side effects. Experts said the developments may prompt calls for tighter guidelines to ensure that recipients were carefully monitored for adverse reactions.
Dr. Paul A. Offit, a vaccine expert and member of an outside advisory panel that recommended the Food and Drug Administration authorize the Pfizer vaccine for emergency use, said the appropriate precautions were already in place. For instance, he said, the requirement that recipients remain in place for 15 minutes after getting the vaccine helped ensure the woman was quickly treated.
âI donât think this means we should pauseâ vaccine distribution, he said. âNot at all.â But he said researchers need to figure out âwhat component of the vaccine is causing this reaction.â
Dr. Jay Butler, a top infectious-disease expert with the Centers for Disease Control and Prevention, said the Alaska situation showed that the monitoring system worked. The agency has recommended that the vaccine be administered in settings that have supplies, including oxygen and epinephrine, to manage anaphylactic reactions.
Millions of Americans are in line to be inoculated with the Pfizer vaccine by the end of the year. As of Wednesday night, it was unclear how many Americans so far have received it. Alex M. Azar II, the health and human services secretary, said his department would be releasing that data âseveral days or maybe a week into this.â
The Alaska womanâs reaction was believed to be similar to the anaphylactic reactions two health workers in Britain experienced after receiving the Pfizer-BioNTech vaccine last week. Like her, both recovered.
Those cases are expected to come up on Thursday, when F.D.A. scientists are scheduled to meet with the agencyâs outside panel of experts to decide whether to recommend that regulators approve Modernaâs Covid-19 vaccine for emergency use.
Although the Moderna and Pfizer-BioNTech vaccines are based on the same type of technology and similar in their ingredients, it is not clear whether an allergic reaction to one would occur with the other. Both consist of genetic material called mRNA encased in a bubble of oily molecules called lipids, although they use different combinations of lipids.
Dr. Offit said that in both vaccines, the bubbles are coated with a stabilizing molecule called polyethylene glycol that he considered a âleading contenderâ for triggering an allergic reaction. He stressed that more investigation was needed.
Pfizerâs trial [did not find any serious adverse events](https://www.nytimes.com/2020/12/08/health/covid-vaccine-pfizer.html) caused by the vaccine, although many participants did experience aches, fevers and other side effects. The Alaska reactions were assumed to be related to the vaccine because they occurred so quickly after the shot.
A Pfizer spokeswoman, Jerica Pitts, said the company did not yet have all of the details of the Alaska situation but was working with local health authorities. The vaccine comes with information warning that medical treatment should be available in case of a rare anaphylactic event, she said. âWe will closely monitor all reports suggestive of serious allergic reactions following vaccination and update labeling language if needed,â Ms. Pitts said.
After the workers in Britain fell ill, authorities there warned against giving the vaccines to anyone with a history of severe allergic reactions. They later [clarified their concerns,](https://www.gov.uk/government/news/confirmation-of-guidance-to-vaccination-centres-on-managing-allergic-reactions-following-covid-19-vaccination-with-the-pfizer-biontech-vaccine) changing the wording from âsevere allergic reactionsâ to specify that the vaccine should not be given to anyone who has ever had an anaphylactic reaction to a food, medicine or vaccine. That type of reaction to a vaccine is âvery rare,â they said.
Pfizer officials have said the two British people who had the reaction had a history of severe allergies. One, a 49-year-old woman, had a history of egg allergies. The other, a 40-year-old woman, had a history of allergies to several medications. Both carried EpiPen-like devices to inject themselves with epinephrine in case of such a reaction.
Pfizer has said that its vaccine does not contain egg ingredients.
The British update also said that a third patient had a âpossible allergic reaction,â but did not describe it.
In the United States, federal regulators issued a broad authorization for the vaccine on Friday to adults 16 years and older. Health care providers were warned not to give the vaccine to anyone with a âknown history of a severe allergic reactionâ to any component of the vaccine, which they said was a standard warning for vaccines.
But because of the British cases, F.D.A. officials have said they would require Pfizer to increase its monitoring for anaphylaxis and submit data on it once the vaccine comes into further use. Pfizer also said the vaccine was recommended to be administered in settings that have access to equipment to manage anaphylaxis. Last weekend, the C.D.C. said people with serious allergies could be safely vaccinated, with close monitoring for 30 minutes after receiving the shot.
Anaphylaxis can be life-threatening, with impaired breathing and drops in blood pressure that usually occur within minutes or even seconds after exposure to a food or medicine, or even a substance like latex to which the person is allergic.
Carl Zimmer contributed reporting.
[Noah Weiland](https://www.nytimes.com/by/noah-weiland) is a reporter in the Washington bureau of The New York Times, covering health care. He was raised in East Lansing, Michigan and graduated from the University of Chicago.
[Sharon LaFraniere](https://www.nytimes.com/by/sharon-lafraniere) is an investigative reporter. She was part of a team that won a Pulitzer Prize in 2018 for national reporting on Donald Trumpâs connections with Russia.
[Mike Baker](https://www.nytimes.com/by/mike-baker) is the Seattle bureau chief, reporting primarily from the Northwest and Alaska.
[Katie Thomas](https://www.nytimes.com/by/katie-thomas) covers the business of health care, with a focus on the drug industry. She started at The Times in 2008 as a sports reporter.
A version of this article appears in print on Dec. 17, 2020, Section A, Page 7 of the New York edition with the headline: Health Worker Hospitalized After Vaccine. [Order Reprints](https://nytimes.wrightsmedia.com/) \| [Todayâs Paper](https://www.nytimes.com/section/todayspaper) \| [Subscribe](https://www.nytimes.com/subscriptions/Multiproduct/lp8HYKU.html?campaignId=48JQY)
## Related Content
[The Covid-19 Pandemic](https://www.nytimes.com/news-event/coronavirus)
- 
Eric Lee/The New York Times
- 
Tierney L. Cross/The New York Times
- Andrea Verdelli for The New York Times
[More in Health](https://www.nytimes.com/section/health)
- 
Kholood Eid for The New York Times
- 
Lucy Lu for The New York Times
- 
Warrick Page/HBO Max
- 
Federica Bordoni
Editorsâ Picks
- 
Christopher Testani for The New York Times. Food Stylist: Simon Andrews.
- 
Alexandre Juillet/Chamonix-Mont Blanc
Trending in The Times
- 
Illustration by Richard a Chance
- 
Photo Illustration by Ioulex for The New York Times
- 
Janet Mac
- 
Lauren Petracca for The New York Times
- 
Noah Kalina for The New York Times
- 
Jason Schmidt
- 
Kent Edwards/Reuters
- 
Aleksey Kondratyev for The New York Times
- 
National Portrait Gallery, London
- 
Scott McIntyre for The New York Times
Advertisement
[SKIP ADVERTISEMENT](https://www.nytimes.com/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html#after-bottom) |
| Shard | 84 (laksa) |
| Root Hash | 4566504020376537684 |
| Unparsed URL | com,nytimes!www,/2020/12/16/health/covid-pfizer-vaccine-allergic-reaction.html s443 |